Compare FCNCO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCNCO | SNN |
|---|---|---|
| Founded | 1898 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 12.3B |
| IPO Year | 1995 | 2002 |
| Metric | FCNCO | SNN |
|---|---|---|
| Price | $19.55 | $26.93 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 19.7K | ★ 1.8M |
| Earning Date | 10-23-2025 | 03-16-2026 |
| Dividend Yield | ★ 6.17% | 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 97.95 | N/A |
| Revenue | ★ $9,541,000,000.00 | N/A |
| Revenue This Year | $0.56 | $8.58 |
| Revenue Next Year | $2.24 | $5.60 |
| P/E Ratio | ★ $0.20 | $64.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.52 | $26.52 |
| 52 Week High | $23.43 | $37.51 |
| Indicator | FCNCO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 33.77 |
| Support Level | N/A | N/A |
| Resistance Level | $20.91 | $31.36 |
| Average True Range (ATR) | 0.34 | 0.47 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 3.48 | 19.02 |
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.